Scarica l'app Stockscreener
168.27
6.84%
10.69
Dopo l'orario di chiusura:
167.44
-0.83
-0.49%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GH Giù?
Forum
Previsione
Guardant Health Inc Borsa (GH) Ultime notizie
Patrick Dempsey Urges Screening With Guardant's Shield Blood Test - Stock Titan
Actor and Cancer Advocate Patrick Dempsey Stars in Emotional Tribute Video From Guardant Health Memorializing Those Who Have Lost Their Lives to Colorectal Cancer - New Castle News
Freenome secures FDA nod for blood-based colorectal cancer test - MedTech Dive
FDA approves Freenome’s blood test for colorectal cancer screening - WTVB
FDA approves Freenome's blood test for colorectal cancer screening - Reuters
Orbimed Advisors LLC Buys Shares of 435,200 Guardant Health, Inc. $GH - MarketBeat
Styrax Capital LP Purchases 18,411 Shares of Guardant Health, Inc. $GH - MarketBeat
First Light Asset Management LLC Sells 14,452 Shares of Guardant Health, Inc. $GH - MarketBeat
Caxton Associates LLP Invests $831,000 in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. (GH) stock price, news, quote and history - Yahoo Finance UK
Guardant Health, Inc. $GH Shares Sold by Aristotle Atlantic Partners LLC - MarketBeat
Guardant Health Inc (GH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Guardant Health, Inc. (GH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Guardant Health, Inc. (GH) Stock Forecasts - Yahoo Finance
Guardant Health: An Expensive Price For A Great Company - Seeking Alpha
Guardant Health, Inc. $GH Shares Sold by Atika Capital Management LLC - MarketBeat
Guardant Health Inc (GH) Institutional Confidence - TradingKey
ETFs Investing in Guardant Health, Inc. Stocks - TradingView
Guardant Health (GH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Hsbc Holdings PLC Has $9.13 Million Stake in Guardant Health, Inc. $GH - MarketBeat
Principal Financial Group Inc. Has $17.07 Million Stock Position in Guardant Health, Inc. $GH - MarketBeat
GH|Guardant Health Inc|Price:147.330|Chg%:-2.870 - TradingKey
Guardant Health (GH) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Form 4 Guardant Health Inc For: 22 July By Investing.com - Investing.com South Africa
Temasek Holdings Private Ltd Sells 58,526 Shares of Guardant Health, Inc. $GH - MarketBeat
Jennison Associates LLC Sells 966,559 Shares of Guardant Health, Inc. $GH - MarketBeat
Global Cancer Biomarkers Market to Reach $37.8 Billion by 2035 as Precision Oncology Adoption Accelerates - GlobeNewswire Inc.
Biomarker Collaboration and Licensing Deals Report 2016-2026Featuring Quanterix, Caris Life Sciences, Alnylam Pharmaceuticals, Guardant Health, Eurofins Scientific and More - Yahoo Finance
Strong Results Boosted Guardant Health (GH) in Q2 - Yahoo Finance
Guardant Health, Inc. $GH Stock Position Raised by WCM Investment Management LLC - MarketBeat
Amova Asset Management Americas Inc. Sells 156,738 Shares of Guardant Health, Inc. $GH - MarketBeat
EBITDA per share of Guardant Health, Inc. – LSX:A2N5RY - TradingView
Guardant Health Surges 53% on UnitedHealth Coverage Deal — "Single-Drop Blood Test for Cancer" Becomes Reality - finance.biggo.com
Guardant Health Falls as Recent Rally Appears to Cool - Quiver Quantitative
Lobbying Update: $180,000 of GUARDANT HEALTH lobbying was just disclosed - Quiver Quantitative
Guardant Health, Inc. (GH) Stock Analysis: Unpacking a 48% Revenue Growth in the Diagnostics Sector - DirectorsTalk Interviews
Guardant Health, Inc. $GH Stock Position Raised by D.A. Davidson & CO. - MarketBeat
Allspring Global Investments Holdings LLC Lowers Position in Guardant Health, Inc. $GH - MarketBeat
Responsive Playbooks and the GH Inflection - Stock Traders Daily
Future Fund LLC Increases Position in Guardant Health, Inc. $GH - MarketBeat
Fifth Third Bancorp Raises Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
Form 144 Guardant Health For: 16 July By Investing.com - Investing.com Nigeria
Guardant Health director Tariq Musa sells $18,941 in stock By Investing.com - Investing.com Nigeria
Form 4 Guardant Health Inc For: 16 July By Investing.com - Investing.com Nigeria
GH Maintains Rating by Guggenheim -- Price Target Raised to $190 - GuruFocus
Guardant Health director Tariq Musa sells $18,941 in stock - Investing.com
Musa Tariq plans sale of Guardant Health (NASDAQ: GH) common stock - Stock Titan
Canadian AI Microcap Cut Hospital Drug Alerts by 94%. Now It’s Entering the U.S. (TSXV: SEGN) - Benzinga
Guggenheim raises Guardant Health stock price target on Shield data - Investing.com
Guggenheim raises Guardant Health stock price target on Shield data By Investing.com - Investing.com Canada
Goldman Sachs Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $185 - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
TD Cowen raises Guardant Health stock price target on FDA approval - Investing.com
How Expanded Coverage for Guardant’s Shield Test Will Impact UnitedHealth Group (UNH) Investors - simplywall.st
GH Maintained by Canaccord Genuity -- Price Target Raised to $20 - GuruFocus
CCORF Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $205 - Moomoo
0.30%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):